National Guideline Clearinghouse | Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer.

Guideline Title
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Jul. 45 p. (Technology appraisal guidance; no. 192).

Guideline Status
This is the current release of the guideline.

full-text:
National Guideline Clearinghouse | Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer.